F.D.A. revises instructions for use of abortion drug Mifeprex; women's health advocates hail victory
SILVER SPRING, Md., March 30 (UPI) -- The FDA said Wednesday it has relaxed its official requirements for the use of the abortion drug Mifeprex, which were based on outdated 1990s medical evidence.